• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; MITRACLIP DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; MITRACLIP DELIVERY SYSTEM Back to Search Results
Catalog Number CDS0501
Device Problems Failure To Adhere Or Bond (1031); Detachment Of Device Component (1104); Improper or Incorrect Procedure or Method (2017); Incomplete Coaptation (2507)
Patient Problems Embolism (1829); Foreign Body In Patient (2687)
Event Date 04/30/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant products: steerable guide catheter, 1 implanted mitraclip, pacemaker.(b)(4).The clip remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
This report is filed since the deployed mitraclip detached and embolized into the pulmonary artery.It was reported that this was a mitraclip procedure treating tricuspid regurgitation (tr) grade 4.The patient presented with a pacing lead and thin tricuspid leaflets.The first clip delivery system (cds) was advanced and there was difficulty grasping the leaflets due to a pre-existing pacing lead.The mitraclip was implanted on the tricuspid leaflets, reducing the tr to grade 2.In attempt to further reduce tr, cds 71027u165 was deployed on the tricuspid leaflets.Once deployed, the mitraclip detached from the posterior leaflet and was hanging on the tip of the anterior septal leaflet.This clip then completely detached and embolized into the pulmonary artery.It was decided to leave the embolized clip in the pulmonary artery.The procedure was ended and the final tr was grade 2.Reportedly, the patient is doing well and the hepatic flow which was reversed prior to the mitraclip procedure had normalized post procedure.No additional information was provided regarding this issue.
 
Manufacturer Narrative
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Review of the complaint-handling database was performed for the reported lot and did not indicate a lot-specific quality issue.Based on the information reviewed, there is no indication of a product quality issue with respect to design, manufacturing, or labeling of the device.All available information was investigated and the reported difficulty grasping, single leaflet device attachment and complete clip detachment appears to be related to the challenging patient morphology/pathology.The reported embolism and foreign body in patient were due to the complete clip detachment.The reported use error (improper or incorrect procedure or method) was associated with the use of the mitraclip device on the tricuspid valve, which is considered an off-label use of the device.It should be noted that the mitraclip instructions for use (ifu) under the indication for use section on page 3 states: the mitraclip nt clip delivery system is indicated for the percutaneous reduction of significant symptomatic mitral regurgitation (mr >/ 3+) due to primary abnormality of the mitral apparatus [degenerative mr] in patients who have been determined to be at prohibitive risk for mitral valve surgery by a heart team, which includes a cardiac surgeon experienced in mitral valve surgery and a cardiologist experienced in mitral valve disease, and in whom existing comorbidities would not preclude the expected benefit from reduction of the mitral regurgitation.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT
Type of Device
MITRACLIP DELIVERY SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
MENLO PARK, CA REG# 3005070406
abbott vascular
26531 ynez rd.
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key7535378
MDR Text Key108976212
Report Number2024168-2018-03827
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/27/2018
Device Catalogue NumberCDS0501
Device Lot Number71027U165
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/30/2018
Initial Date FDA Received05/22/2018
Supplement Dates Manufacturer Received08/20/2018
Supplement Dates FDA Received08/22/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age77 YR
Patient Weight87
-
-